Radiotherapy and tamoxifen after mastectomy in postmenopausal women - 20 year follow-up of the South Sweden Breast Cancer group randomised trial SSBCG II:I

European Journal of Cancer

Volumn 43, Issue 14, 2007, Pages 2100-2108

  Killander, Fredrika ^a   Anderson, Harald ^b   Rydén, Stefan ^c   Möller, Torgil ^b   Aspegren, Knut ^d   Ceberg, Jeanette ^b   Danewid, Christina ^b   Malmström, Per ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c Emergency Medical Services   (Sweden)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Breast cancer; Local recurrence; Long term; Mastectomy; Mortality; Radiotherapy; Tamoxifen

Indexed keywords

TAMOXIFEN; TAMOXIFEN CITRATE;

ADULT; ARM EDEMA; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; IRRADIATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MORTALITY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PNEUMONIA; POSTMENOPAUSE; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, RADICAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTMENOPAUSE; SURVIVAL ANALYSIS; TAMOXIFEN; TREATMENT OUTCOME;

EID: 34548479956     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.05.026     Document Type: Article

References (31)

1. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 9503 (2005) 2087-2106
2. Muss H.B., Cooper M.R., Brockschmidt J.K., et al. A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer. Eleven year follow-up of a Piedmont Oncology Association trial. Breast Cancer Res Treat 19 2 (1991) 77-84
3. Overgaard M. Postoperative radiotherapy in high-risk premenopausal women with breastcancer who receive adjuvant chemotherapy. NE J Med 337 14 (1997) 949-955
4. Overgaard M. Postoperative radiotherapy in highrisk postmenopausal breastcancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 535 (1999) 1641-1648
5. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 2 (2005) 116-126
6. Whelan T.J., Julian J., Wright J., Jadad A.R., and Levine M.L. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 6 (2000) 1220-1229
7. Overgaard M. Evaluation of radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. Rays 25 3 (2000) 325-330
8. Rutqvist L.E., Pettersson D., and Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: long-term follow-up of a randomized clinical trial. Radiother Oncol 26 2 (1993) 104-110
9. Ryden S., Ferno M., Borg A., Hafstrom L., Moller T., and Norgren A. Prognostic significance of estrogen and progesterone receptors in stage II breast cancer. J Surg Oncol 37 4 (1988) 221-226
10. Ryden S., Ferno M., Moller T., et al. Long-term effects of adjuvant tamoxifen and/or radiotherapy. The South Sweden Breast Cancer Trial. Acta Oncol 31 2 (1992) 271-274
11. Ryden S., Moller T., Hafstrom L., Ranstam J., Westrup C., and Wiklander O. Adjuvant therapy of breast cancer: compliance and data validity in a multicenter trial. Control Clin Trials 7 4 (1986) 290-305
12. Tennvall-Nittby L., Tengrup I., and Landberg T. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. Acta Oncol 32 6 (1993) 641-646
13. EBCTCG (European Breast Cancer Trialists Collaboration Group). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365(9472):1687-1717.
14. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 5 (2001) 1539-1569
15. ICRU report 29, Dose specification for reporting external beam therapy with photons and electrons; 1978.
16. Arwidi A., Aspegren K., Augustsson N.E., Hafstrom L., Norgren A., and Svahn-Tapper G. Postoperative radiation therapy in mammary carcinoma stage II. Target volume, organs at risk, absorbed dose, time-dose schedule, and dose to organs at risk in a prospective investigation. Acta Radiol Oncol Radiat Phys Biol 18 4 (1979) 273-281
17. Schulgen G., Schmoor C., Sauerbrei W., and Schumacher M. A note on estimating local recurrence rates in clinical trials on the treatment of breast cancer. Breast Cancer Res Treat 49 1 (1998) 87-91
18. Veronesi U., Marubini E., Del Vecchio M., et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87 1 (1995) 19-27
19. Kalbfleisch J., and Prentice R. The statistical analysis of failure time data (1980), Wiley, New York
20. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 9263 (2001) 1191-1194
21. Host H., Brennhovd I.O., and Loeb M. Postoperative radiotherapy in breast cancer - long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12 5 (1986) 727-732
22. Rutqvist L.E., and Johansson H. Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients. Acta Oncol 45 5 (2006) 517-527
23. van der Hage J.A., Putter H., Bonnema J., Bartelink H., Therasse P., and van de Velde C.J. Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis. Eur J Cancer 39 15 (2003) 2192-2199
24. Fodor J., Polgar C., Major T., and Nemeth G. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size. Strahlenther Onkol 179 3 (2003) 197-202
25. Katz A., Strom E.A., Buchholz T.A., et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 18 15 (2000) 2817-2827
26. Recht A., Gray R., Davidson N.E., et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17 6 (1999) 1689-1700
27. Taghian A., Jeong J.H., Mamounas E., et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22 21 (2004) 4247-4254
28. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 3 (1994) 447-453
29. Haybittle J.L., Brinkley D., Houghton J., A'Hern R.P., and Baum M. Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ 298 6688 (1989) 1611-1614
30. Jones J.M., and Ribeiro G.G. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol 40 2 (1989) 204-208
31. Hojris I., Overgaard M., Christensen J.J., and Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 354 9188 (1999) 1425-1430